Please ensure Javascript is enabled for purposes of website accessibility

Emergent BioSolutions secures $90M COVID vaccine development, manufacturing agreement (access required)

Gaithersburg-based Emergent BioSolutions Inc. and Providence Therapeutics have entered into an agreement to support Providence's COVID-19 vaccine development.